Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the...
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through...
Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally...
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically...
Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this...
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which...
Written by SOMAÍ Pharmaceuticals CEO, Michael Sassano For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the...
Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the...
The UK’s first international prescribing service has launched for medical cannabis patients travelling to the country from overseas.
Experts explore how Medical Cannabis may play a role in addressing cardiovascular issues.
